Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Anything...



Profile for Enanta Pharmaceuticals, Inc. (ENTA)

« Back to company index

ENTA Chatter Timeline

Stock Ticker for ENTA

Most Active Tweeters for ENTA

No tweets found

Recent Tweets for ENTA

MarcJacksonLA @MarcJacksonLA
$ENTA Enanta Pharmaceuticals Presents Data for its COVID-19 and Respiratory Syncytial Virus Programs at the 33rd Eu… https://t.co/SWr1CZsJIy
April 17th 2023, 3:04pm
otcdynamics @otcdynamics
$ENTA Enanta Pharmaceuticals Presents Data for its COVID-19 and Respiratory Syncytial Virus Programs at the 33rd Eu… https://t.co/3KLrokItds
April 17th 2023, 12:04pm
otcdynamics @otcdynamics
$ENTA Enanta Pharmaceuticals Presents Data for its COVID-19 and Respiratory Syncytial Virus Programs at the 33rd Eu… https://t.co/v7w6XQno3t
April 17th 2023, 12:04pm
James__BondOO7 @James__BondOO7
RT @stock_titan: $ENTA Enanta Pharmaceuticals Presents Data for its COVID-19 and Respiratory Syncytial Virus Programs at the 33rd European…
April 17th 2023, 11:04am
FlashAlert_me @FlashAlert_me
$ENTA [15s. delayed]: Issued Press Release on April 17, 07:00:00: Enanta Pharmaceuticals Presents Data for its COVI… https://t.co/80CxEUW7s4
April 17th 2023, 11:04am
StockNewsBot2 @StockNewsBot2
$ENTA Enanta Pharmaceuticals Presents Data for its COVID-19 and Respiratory Syncytial Virus Programs at the 33rd Eu… https://t.co/FgbjTEtIks
April 17th 2023, 11:04am
stock_titan @stock_titan
$ENTA Enanta Pharmaceuticals Presents Data for its COVID-19 and Respiratory Syncytial Virus Programs at the 33rd Eu… https://t.co/WIYKlDZPcl
April 17th 2023, 11:04am
WebChronicleTo1 @WebChronicleTo1
$ENTA Enanta Pharmaceuticals Presents Data for its COVID-19 and Respiratory Syncytial Virus Programs at the 33rd Eu… https://t.co/DbQ8nWYgbD
April 17th 2023, 11:04am
Tickeron @Tickeron
This is why Hedge Funds use A.I. $ENTA RSI Indicator left the oversold zone. #EnantaPharmaceuticals… https://t.co/WD676YltRN
April 13th 2023, 11:04pm
LeviTrade2 @LeviTrade2
$ENTA Buy rating based off 6 trades on the 15-min chart. #trading #stocks #wallstreet #webull #tradingview #tos ? C… https://t.co/txhpDrOJwA
April 12th 2023, 11:04am
TortozaPalma @TortozaPalma
$ENTA Awaiting Buy Signal based off 6 signals on the 15-min chart. Free trial at https://t.co/OB4KuLJjyA https://t.co/3atUCYlztS
April 12th 2023, 2:04am
Tickeron @Tickeron
How does this affect your portfolio? $ENTA RSI Indicator left the oversold zone. #EnantaPharmaceuticals… https://t.co/tECftg4R5r
April 8th 2023, 6:04am
StckPro @StckPro
$ENTA NEW ARTICLE : RBC Capital Keeps Their Hold Rating on Enanta Pharmaceuticals (ENTA) https://t.co/ghn5DA2Q5t
April 8th 2023, 1:04am
bkfViking123 @bkfViking123
RT @MarcJacksonLA: $ENTA Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Developme…
April 6th 2023, 3:04pm
MarcJacksonLA @MarcJacksonLA
$ENTA Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Deve… https://t.co/PLM0hxhYgW
April 6th 2023, 3:04pm
OzmosiHealth @OzmosiHealth
$ENTA receives FDA Fast Track Designation for EDP-323, an oral L-Protein inhibitor in development for the treatment… https://t.co/wpLdH2BLkJ
April 6th 2023, 1:04pm
Briefingcom @Briefingcom
$ENTA: Enanta Pharmaceuticals announces that the U.S. Food and Drug Administration has granted Fast Track... https://t.co/QwCPfvrVk2
April 6th 2023, 1:04pm
realmaciej @realmaciej
RT @BioStocks: $ENTA Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Development for the Treatment of Res…
April 6th 2023, 12:04pm
otcdynamics @otcdynamics
$ENTA Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Deve… https://t.co/KiqFrdKSmp
April 6th 2023, 12:04pm
thudderwicks @thudderwicks
$ENTA said that the FDA has granted Fast Track designation for EDP-323, Enanta’s L-protein inhibitor in development… https://t.co/unKOzCgxpH
April 6th 2023, 11:04am
StckPro @StckPro
$ENTA NEW ARTICLE : Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inh… https://t.co/mJN6hHc4xd
April 6th 2023, 11:04am
Tradesense_me @Tradesense_me
$ENTA ? ? Press Release Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protei… https://t.co/WiVxdsZTSj
April 6th 2023, 11:04am
TheTradeXchange @TheTradeXchange
$ENTA: Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Dev… https://t.co/2Abh9qn290
April 6th 2023, 11:04am
James__BondOO7 @James__BondOO7
RT @stock_titan: $ENTA Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Development…
April 6th 2023, 11:04am
FlashAlert_me @FlashAlert_me
$ENTA [15s. delayed]: Issued Press Release on April 06, 07:00:00: Enanta Pharmaceuticals Receives FDA Fast Track De… https://t.co/G20LDC1cj4
April 6th 2023, 11:04am
BioStocks @BioStocks
$ENTA Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Development for the Treatme… https://t.co/i0Iyn8GAPY
April 6th 2023, 11:04am
StockNewsBot2 @StockNewsBot2
$ENTA Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Deve… https://t.co/btqfYCmPQ8
April 6th 2023, 11:04am
WebChronicleTo1 @WebChronicleTo1
$ENTA Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Deve… https://t.co/7TmHWeWQN7
April 6th 2023, 11:04am
CHItraders @CHItraders
$ENTA Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Deve… https://t.co/cy6tf7VQYl
April 6th 2023, 11:04am
stock_titan @stock_titan
$ENTA Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhibitor in Deve… https://t.co/8yQPFKfuux
April 6th 2023, 11:04am
bthefirsttoknow @bthefirsttoknow
First out// $ENTA: Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-323, its Oral, L-Protein Inhi… https://t.co/hJFtUIOQEV
April 6th 2023, 11:04am
otcdynamics @otcdynamics
$ENTA Enanta Pharmaceuticals to Present Data at the 33rd European Congress of Clinical Microbiology and Infectious… https://t.co/Gz38WVsTUM
April 5th 2023, 11:04am
FlashAlert_me @FlashAlert_me
$ENTA [15s. delayed]: Issued Press Release on April 05, 07:00:00: Enanta Pharmaceuticals to Present Data at the 33r… https://t.co/dq53HVDFIt
April 5th 2023, 11:04am
Tradesense_me @Tradesense_me
$ENTA ? ? Press Release Enanta Pharmaceuticals to Present Data at the 33rd European Congress of Clinical Microbiol… https://t.co/pHn0xlnpxi
April 5th 2023, 11:04am
StockNewsBot2 @StockNewsBot2
$ENTA Enanta Pharmaceuticals to Present Data at the 33rd European Congress of Clinical Microbiology and Infectious… https://t.co/XIXx3hbefS
April 5th 2023, 11:04am
WebChronicleTo1 @WebChronicleTo1
$ENTA Enanta Pharmaceuticals to Present Data at the 33rd European Congress of Clinical Microbiology and Infectious… https://t.co/hxeMsqdMPP
April 5th 2023, 11:04am
stock_titan @stock_titan
$ENTA Enanta Pharmaceuticals to Present Data at the 33rd European Congress of Clinical Microbiology and Infectious… https://t.co/mRb8FQsuwE
April 5th 2023, 11:04am
ChartMill @ChartMill
$ENTA is expected to show a strong revenue growth of 64.25% yearly. https://t.co/KkoF1p5wg1 https://t.co/mbyr11IHSk
April 3rd 2023, 8:04pm
StckPro @StckPro
$ENTA NEW ARTICLE : Enanta Pharmaceuticals (ENTA) Receives a Buy from JMP Securities https://t.co/KUXF3zaozP
April 3rd 2023, 2:04pm
Phoenix3million @Phoenix3million
$enta entered 5k shares 2day. $rvnc entered 2.5K shares. very familiar w/ both for past 5 years. Current holdin… https://t.co/nxb18EFThO
March 23rd 2023, 3:03pm
StockAutomate @StockAutomate
$ENTA The chart is showing a bearish outlook for the stock. We alerted the SELL signal at $41.94 and we were able t… https://t.co/jftMrOzqxI
March 22nd 2023, 5:03am
fda_tracker @fda_tracker
$ENTA Phase 2 trial w/est Mar completion date NCT05616728: https://t.co/c9YEhMGw74 Trial Tracker: https://t.co/aR7q5osthn
March 21st 2023, 1:03pm
gtrades31 @gtrades31
$ENTA Blocktrade Sale of $1.22M SHARES 29.35K ? Filled at Bid @ 41.73 #Blocktrades
March 20th 2023, 9:03pm
mediasentiment @mediasentiment
$ENTA new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 185
March 20th 2023, 9:03am
mediasentiment @mediasentiment
$ENTA new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 184
March 20th 2023, 9:03am
PaulTorresCohen @PaulTorresCohen
Paul Torres-Cohen $ENTA
March 20th 2023, 1:03am
Tickeron @Tickeron
$ENTA's 10-day Moving Average broke below its 50-day Moving Average on February 28, 2023. View odds for this and ot… https://t.co/rOPy1SzFX6
March 19th 2023, 4:03pm
Tickeron @Tickeron
How will this affect the market? $ENTA price may climb as it broke lower Bollinger Band. #EnantaPharmaceuticals… https://t.co/ixLFXG1Bhd
March 18th 2023, 10:03pm
FlashAlert_me @FlashAlert_me
$ENTA [15s. delayed] filed SEC form 4: Director Vance Terry: Converted securities 5,800 of Common Stock at price $… https://t.co/vFWYL5OYB0
March 17th 2023, 10:03pm
day_trading_de @day_trading_de
ENTA (ENANTA PHARMACEUTICALS INC) ? #Insider #stock alert! ? #Sale on 2023-03-15 - $ENTA ??: MELLETT PAUL J (Treasu… https://t.co/c0gsH39H6h
March 17th 2023, 10:03pm

DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2023. All rights reserved.